BioSpace News Archive

Sensus Healthcare, Inc., a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces financial results for the three months ended March 31, 2020.

Helius Medical Technologies, Inc., a neurotech company focused on neurological wellness, reported financial results for the quarter ended March 31, 2020.

Optinose, a pharmaceutical company focused on patients treated by ear, nose and throat and allergy specialists, reported financial results for the quarter ended March 31, 2020, and provided operational updates.

Entasis Therapeutics Holdings Inc., a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, announced its first quarter 2020 financial results and provided a business update.

Profound Medical Corp., the only company to provide customizable, incision-free therapies which combine real-time Magnetic Resonance Imaging, thermal ultrasound and closed-loop temperature feedback control for the radiation-free ablation of diseased tissue, reported financial results for the first quarter ended March 31, 2020, and provided an update on its operations.

Guardant Health, Inc., a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics, reported financial results for the quarter ended March 31, 2020.

BioDelivery Sciences International, Inc., a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, reported strong financial results for the first quarter ended March 31, 2020, as well as the following operational and performance highlights.

Enrollment on track in Controlled IL-12 phase 2 clinical trial with Regeneron’s Libtayo®; Controlled IL-12 clinical data update at ASCO 2020

Cytokinetics, Incorporated announced that its Annual Meeting of Stockholders will be held on Wednesday, May 13, 2020 at 10:30 AM Pacific Time at the Company’s headquarters, 280 East Grand Avenue, South San Francisco, CA.

Establishment Labs Holdings Inc., a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, announced its financial results for the first quarter ended March 31, 2020.